1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023-38.

https://doi.org/10.1016/S0140-6736(16)30173-8

PMid:27156434 

2. Lin YJ, Anzaghe M, Schülke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 2020;9:880.

https://doi.org/10.3390/cells9040880

PMid:32260219 PMCid:PMC7226834

3. Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A. Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmun Rev. 2021;20:102776.

https://doi.org/10.1016/j.autrev.2021.102776

PMid:33609792 

4. Compston J. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018;61:7-16.

https://doi.org/10.1007/s12020-018-1588-2

PMid:29691807 PMCid:PMC5997116

5. Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol. 2017;69:1521-37.

https://doi.org/10.1002/art.40137

PMid:28585373 

6. Kareem R, Botleroo RA, Bhandari R, Ogeyingbo OD, Ahmed R, Gyawali M, et al. The Impact of Rheumatoid Arthritis on Bone Loss: Links to Osteoporosis and Osteopenia. Cureus. 2021;13:e17519.

https://doi.org/10.7759/cureus.17519

PMid:34603889

7. Tanaka Y. Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview. J Clin Med. 2021;10:1241.

https://doi.org/10.3390/jcm10061241

PMid:33802804 PMCid:PMC8002542

8. Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg. 2022;80:920-43.

https://doi.org/10.1016/j.joms.2022.02.008

PMid:35300956 

9. Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Systematic reviews of etiology and risk. JBI. 2020.

https://doi.org/10.46658/JBIRM-17-06

PMid:

10. Bezerra CT, Grande AJ, Galvão VK, Santos DHMD, Atallah ÁN, Silva V. Assessment of the strength of recommendation and quality of evidence: GRADE checklist. A descriptive study. Sao Paulo Med J. 2022;140:829-36.

PMid:36102459

11. Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106-10.

https://doi.org/10.1136/bmj.39500.677199.AE

PMid:18483053 PMCid:PMC2386626

12. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401-6.

https://doi.org/10.1016/j.jclinepi.2010.07.015

PMid:21208779 

13. Murad MH, Mustafa RA, Schünemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22:85-7.

https://doi.org/10.1136/ebmed-2017-110668

PMid:28320705 PMCid:PMC5502230

14. Chiu WY, Chien JY, Yang WS, Juang JM, Lee JJ, Tsai KS. The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene. J Clin Endocrinol Metab. 2014;99:2729-35.

https://doi.org/10.1210/jc.2013-4119

PMid:24758181 

15. Furuya T, Maeda S, Momohara S, Taniguchi A, Yamanaka H. Dental treatments, tooth extractions, and osteonecrosis of the jaw in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study. J Bone Miner Metab. 2017;35:344-50.

https://doi.org/10.1007/s00774-016-0763-x

PMid:27372662 

16. Chiu WY, Yang WS, Chien JY, Lee JJ, Tsai KS. The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects. PLoS One. 2018;13:e0196419.

https://doi.org/10.1371/journal.pone.0196419

PMid:29694412 PMCid:PMC5918995

17. Quintana-González M, Quintana-Montesdeoca P, Gómez de Tejada-Romero MJ, Saavedra-Santana P, Vicente-Barrero M, Bocanegra-Pérez S, et al. Qualitative and quantitative status of general bone in osteonecrosis of the jaws. Effect of bisphosphonates. Rev Osteoporos Metab Miner. 2019;11:55-63.

https://doi.org/10.4321/S1889-836X2019000200004

PMid:

18. Kim SH, Lee YK, Kim TY, Ha YC, Jang S, Kim HY. Incidence of and risk for osteonecrosis of the jaw in Korean osteoporosis patients treated with bisphosphonates: A nationwide cohort-study. Bone. 2021;143:115650.

https://doi.org/10.1016/j.bone.2020.115650

PMid:32956854 

19. Lescaille G, Coudert AE, Baaroun V, Javelot MJ, Cohen-Solal M, Berdal A, et al. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?. J Rheumatol. 2013;40:781-6.

https://doi.org/10.3899/jrheum.120810

PMid:23504384 

20. de Molon RS, Hsu C, Bezouglaia O, Dry SM, Pirih FQ, Soundia A, et al. Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study. J Bone Miner Res. 2016;31:1596-607.

https://doi.org/10.1002/jbmr.2827

PMid:26950411 PMCid:PMC4970902

21. González-Chávez SA, Pacheco-Tena C, de Jesús Caraveo-Frescas T, Quiñonez-Flores CM, Reyes-Cordero G, Campos-Torres RM. Oral health and orofacial function in patients with rheumatoid arthritis. Rheumatol Int. 2020;40:445-53.

https://doi.org/10.1007/s00296-019-04440-3

PMid:31531708 

22. Furuya T. Clinical observations of osteoporosis in Japanese patients with rheumatoid arthritis. Mod Rheumatol. 2022;32:839-45.

https://doi.org/10.1093/mr/roab130

PMid:34979563 

23. Sacco R, Shah S, Leeson R, Moraschini V, de Almeida Barros Mourão CF, Akintola O, et al. Osteonecrosis and osteomyelitis of the jaw associated with tumour necrosis factor-alpha (TNF-α) inhibitors: a systematic review. Br J Oral Maxillofac Surg. 2020;58:25-33.

https://doi.org/10.1016/j.bjoms.2019.09.023

PMid:31645276